Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe

Search Workers' Comprehensive Articles

  • Reset
Medmonitor
Rezenopy Approved for Treatment of Opioid Overdose

A new naloxone nasal spray will soon be available.

Read More →
This Month's Must Read
Triple Threat: Healthcare Fraud, Waste and Abuse in Workers’ Comp

Identifying and combating a multifaceted problem, including proven and developing strategies.

Read More →
Industry Trends
WCRI Publishes 24th Edition of CompScope Benchmarks

A total of 14 different reports examine workers’ comp system performance across 17 states from 2017-2022.

Read More →
Marijuana Developments
DEA to Reschedule Marijuana

While bureaucratic wheels may take time, marijuana will become a Schedule III drug soon.

Read More →
Healthe Developments
Maximizing Efficiency and Streamlining Claims Management Processes

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present this educational session at PRIMA 2024.

Read More →
Medmonitor
Lot of Methocarbamol Recalled Due to White Particles

Patients taking this muscle relaxant may be impacted by a lot from Eugia US/AuroMedics Pharma.

Read More →
Medmonitor
Cardiovascular Drug Approvals

As firefighters see more presumptions for heart disease, keeping track of heart medications could grow in importance.

Read More →
Industry Trends
2024 Workers’ Comp Industry Insights Survey Report

Visit Healthe at RISKWORLD® 2024 at Booth #1833 for your copy or download a copy now.

Read More →
Legislation & Policy
Rhode Island Proposes Worker Climate Protection

If enacted, Senate Bill 2900 would require worker protections from extreme heat and cold.

Read More →
Legislation & Policy
More States Consider Cancer Presumptions for Firefighters

Different types of cancers are being added to pre-existing presumptions.

Read More →
Healthe Developments
Visit Healthesystems at RISKWORLD 2024

Pick up a copy of the new Summer 2024 edition of RxInformer magazine, and learn how Healthe is transforming healthcare.

Read More →
Medmonitor
New Autoimmune Biosimilar Approved and Alzheimer’s Drug Goes Generic

Simlandi injection was approved for arthritic conditions, while Namzaric receives its first generic approval.

Read More →
This Month's Must Read
Novel Migraine Agents: What is Their Place in Injured Worker Therapy?

As the market grows, it becomes necessary to understand efficacy, costs, and alternatives.

Read More →
Industry Trends
CWCI Reports on Cumulative Trauma in Litigated Claims

Tenure more than age and other factors had a higher association with cumulative trauma claims.

Read More →
Legislation & Policy
AI Utilization Review Bills Appear Across the Country

California, Georgia, New York, Oklahoma, and Pennsylvania could start a national trend.

Read More →
Psychedelic Developments
Three More States Introduce Psychedelics Bills, While FDA Sets MDMA Decision Date

Connecticut, Missouri, and New Hampshire join 10 other states considering psychedelics bills.

Read More →
Healthe Developments
Medical Issues Panel at IAIABC Forum & The Fear of Reinjury in Workers’ Comp

Amanda Waltemath, Director of Clinical Services joins a panel discussion on April 10th, and Tate Rice, Director of Product Management speaks to Risk & Insurance.

Read More →
Medmonitor
FDA Evaluates Report of Suicidal Thoughts with GLP-1 Inhibitors

While no clear link is established to these obesity and diabetes drugs, the FDA will continue to monitor data.

Read More →
This Month's Must Read
2024 Workers’ Comp Industry Insights Survey Report

This sixth annual survey report highlights the top challenges and priorities of 500 industry professionals.

Read More →
Legislation & Policy
U.S. Department of Labor Issues Final Rule on Worker Classification

The rule clarifies differences between employees and contractors, establishing who is entitled to benefits – including workers’ comp.

Read More →
Psychedelic Developments
Ten Psychedelic Bills Introduced Across State Legislatures

States so far include Alaska, Arizona, California, Hawaii, Indiana, Illinois, Massachusetts, Maryland, New Jersey, and Wisconsin.

Read More →
Opioid Developments
FDA Approves First Test to Help Identify Risks of Developing Opioid Use Disorder

The AvertD test is intended to be used prior to first exposure to oral opioids in patients considered for a 4-30 day prescription for acute pain.

Read More →
Marijuana Developments
Department of Health and Human Services Reveals Cannabis Rescheduling Findings

With many federal agencies in alignment, the ultimate decision rests with the DEA.

Read More →
Medmonitor
FDA Issues Respective Warnings for Compounded and Counterfeit Semaglutide

The growing demand for this drug has led individuals to search for semaglutide from alternative sources.

Read More →
This Month's Must Read
The Mind-Body Connection: Exploring the Relationship Between Injury and Mental Health

Injuries accompanied by mental health disorders can increase claim costs and delay recovery.

Read More →
Legislation & Policy
Growing Shifts in Child Labor Laws

Many states passed or proposed changes in 2023, with two states so far working on bills for 2024.

Read More →
Marijuana Developments
White House Pardons Simple Possession Charges for Marijuana

A recent proclamation applies to simple federal possession charges on or before December 22, 2023.

Read More →
Legislation & Policy
PTSD Presumptions Could See More Action in 2024

As legislative sessions open, several states have continued to introduce PTSD bills.

Read More →
Healthe Developments
Emerging/Current Medical and Drug Trends

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present at the 20th Annual Workers’ Compensation Insurance ExecuSummit.

Read More →
Medmonitor
FDA Warns of Rare Drug Interactions with Antiseizure Drugs

Hypersensitivity reactions may start as a rash but can quickly result in injury to internal organs.

Read More →
This Month's Must Read
Beyond Opioids: Drugs of Concern in Workers’ Compensation

As opioid utilization decreases, other pharmacy trends bear watching.

Read More →
Clinical Insights
Comorbidities and Recovery After Physical Therapy for Low Back Pain

A new WCRI report utilizes data from 68,850 workers from 2017-2021.

Read More →
Industry Developments
Bureau of Labor Statistics Reports on Workplace Injuries and Illnesses

Employers reported 2.8 million nonfatal workplace injuries and illnesses in 2022, an increase of 7.5% from 2021.

Read More →
Legislation & Policy
White House Issues Executive Order on Artificial Intelligence

The order seeks increased transparency from AI companies regarding model operations, safety and privacy standards, and consumer/worker protections.

Read More →
Healthe Developments
Industry Wide Trends & Pharmacy Trends

Healthe expertise is featured in Risk & Insurance magazine, both on larger industry trends, and on evolving drug trends.

Read More →
Medmonitor
FDA Approves New Formulation of Combogesic

The acetaminophen and ibuprofen combination was approved for IV use, and as an adjunct to opioid therapy for the treatment of pain.

Read More →
This Month's Must Read
What Do I Need to Know About DME Trends?

A Healthesystems clinical expert tackles questions about Durable Medical Equipment (DME) trends.

Read More →
Clinical Insights
CDC Reports on Mental Health Struggles Amongst Healthcare Workers

Approximately 45.6% of health workers reported feeling burnout often or very often in 2022.

Read More →
Legislation & Policy
California Bans Pre-Employment Marijuana Screening

Similar to a Washington law passed earlier this year, employees are not permitted to possess, to be impaired by, or to use cannabis on the job.

Read More →
Psychedelic Developments
FDA Warns of Risks with Compounded Ketamine Products

The ketamine molecule is not FDA-approved in any formulation for the treatment of psychiatric disorders.

Read More →
Healthe Developments
Healthe Leaders in the Media

Tate Rice and Silvia Sacalis share their respective expertise on key issues in physical therapy and pharmacy management.

Read More →
Medmonitor
New Depression Product and Diabetes Generic Approvals

Exuua was approved for major depressive disorder, while two diabetes medications receive generic approvals.

Read More →
This Month's Must Read
The Real Promise of Artificial Intelligence in Healthcare and Workers’ Comp

Potential applications, benefits, pitfalls, questions, and the matter of regulation.

Read More →
Clinical Insights
Biomarkers in the Blood Could Lead to a Long COVID Test

After studying 273 blood samples, researchers could detect long COVID with 96% accuracy.

Read More →
Legislation & Policy
California Enacts Skin Cancer Presumptions for First Responder and Other Occupations

This law also includes lifeguards, and certain employees in the Departments of Fish and Wildlife and Parks and Recreation.

Read More →
Industry Trends
WCRI Reports on Changes in the Workforce

New insights into how economic and demographic changes have influenced the workers’ comp system.

Read More →
Healthe Developments
Harnessing the Injured Worker’s Influence on Claims Outcomes

Healthe’s VP of Clinical Services, Silvia Sacalis, will co-present this educational session at Florida PRIMA 2023.

Read More →
Clinical Insights
New National Substance Abuse Report

Binge drinking reached a historic high for adults aged 35-50 in 2022.

Read More →
This Month's Must Read
Changing Minds? Unlocking the Potential of Psychedelics in Mental Health Therapy

Clinical research indicates the potential for strong mental health applications.

Read More →
Legislation & Policy
Connecticut Enacts Cancer Presumption for Firefighters

Enacted as part of the state’s budget bill, this new regulation comes with stipulations and exclusions.

Read More →
COVID-19 Developments
WCRI Publishes Long COVID Report

The likelihood of long COVID, claims costs, and claim duration all increased with the severity of acute COVID-19.

Read More →
Opioid Developments
CDC Awards $279M to 49 States for Overdose Prevention

These funds will help states and communities respond more quickly, effectively, and equitably to prevent overdose death and injury.

Read More →
Healthe Developments
Healthe Leaders in the Media

Kristine Kennedy discusses attributes of effective technology for managed care programs, Silvia Sacalis examines post-opioid epidemic medical trends, and Sandy Shtab speaks on marijuana.

Read More →
Medmonitor
Tornado Damages Pfizer Pharmaceutical Plant, Drug Shortages May Follow

As other Pfizer plants shift gears to make up for this damage, overall drug manufacturing may slow in some areas.

Read More →
This Month's Must Read
3 Ways the Digital Experience Can Drive Meaningful Engagement for Injured Workers

Helpful tips for addressing injured worker unfamiliarity with workers’ comp.

Read More →
Clinical Insights
Utilization of Opioid Use Disorder Medications

According to JAMA, only 22% of OUD patients received medication-assisted therapy.

Read More →
Legislation & Policy
Missouri Enacts PTSD Presumption for First Responders

The national trend continues, in this case with qualifying events and the inclusion of 911 dispatchers.

Read More →
Opioid Developments
FDA Approves Second OTC Naloxone Nasal Spray for Opioid Overdose

RiVive will soon be available without a prescription for the treatment of known or suspected opioid overdose.

Read More →
Healthe Developments
Connect with Healthe at National Comp 2023!

Stop by our educational session or visit our booth for the latest issue of RxInformer magazine.

Read More →
Medmonitor
FDA Publishes Guidance on Clinical Trials for Psychedelic Drugs

These guidelines advise researchers on study design and other considerations as they develop medications that contain psychedelics.

Read More →
1 2 3 7

Workers’ Comprehensive

News and views in workers’ comp
Important news in workers’ comp delivered to your inbox
Subscribe
Back to Top
lockenvelopephone-handsetmagnifiercrossmenucross-circle